Loading...
Loading...
When a startup hands you an option grant, the recruiting deck typically shows a hockey-stick projection of what those shares could be worth. What it almost never shows is the base rate — what percentage of startup options pay out at all. After years of analyzing private market exits and advising employees on concentrated equity positions, I can tell you that the gap between the pitch and the historical data is wider than most people realize, and it has real consequences for how you should think about your equity package.
This article walks through the startup option payout statistics that matter, examines the odds of startup stock options paying out across different stages and outcomes, and shows you how to estimate startup equity expected value in a way that is honest about both the upside and the dropout rate. None of this is meant to make you cynical about startup work — it is meant to help you size your bet appropriately.
The blunt answer to what percentage of startup options pay out depends on how you define “pay out.” If we mean any cash to the option holder above the cost of exercise plus taxes, the number for venture-backed startups is generally somewhere in the 5–20% range across most cohorts. If we restrict the definition to a life-changing return, the figure drops dramatically — often into the low single digits.
A frequently cited dataset from CB Insights’ venture capital funnel research tracked roughly 1,100 seed-funded technology companies and found that only about 1% reached unicorn status, around 50% raised a follow-on round, and roughly 70% either died or became zombies — alive but going nowhere. Correlation Ventures’ analysis of more than 21,000 financings between 2004 and 2013 painted a similar picture: about 65% of venture rounds returned less than the capital invested. These are investor-level numbers, but the implications for option holders are even harsher because employees sit behind every preferred preference stack.
Putting concrete numbers on the startup option payout statistics most employees never see during recruiting helps cut through the marketing. Roughly 60–75% of venture-backed startups fail to return capital, according to widely cited work by Harvard Business School professor Shikhar Ghosh and analyses summarized by The Wall Street Journal. Of the survivors, a meaningful portion exit at valuations where common stockholders receive little or nothing because of liquidation preferences sitting on top of them. Median time from founding to a liquidity event has stretched to roughly 10–12 years for venture-backed companies, per data from PitchBook and the National Venture Capital Association.
Within that 10–12 year window, employees often face a 90-day post-termination exercise window. If you leave the company before a liquidity event, you typically have to write a check for your strike price plus any AMT exposure to keep your shares — or watch them expire. The Coinbase direct listing, Stripe’s recurring tender offers, and several IPO postponements during the 2022–2024 market reset are reminders that timing is rarely under the employee’s control.
The odds of startup stock options paying out are not just a function of company quality — they are structurally shaped by the capital stack. Preferred shareholders are paid first in any exit, often with 1x non-participating preferences (sometimes higher in down markets). If your company sells for less than total capital raised, common shareholders — which is what most employee options become upon exercise — receive little or nothing.
There is also concentration risk built into the very structure of a single option grant. Even if you pick a great company, you are taking a binary bet. In my experience analyzing employee equity outcomes, the variance is enormous — two engineers at adjacent Series B startups in 2018 could have ended up with $0 and $5M respectively just based on which logo they accepted. That is not skill; it is variance, and it is worth pricing into how you think about your offer.
Recent market dynamics have made the odds of startup stock options paying out even more sensitive to macro conditions. The 2022 reset, the IPO drought stretching into 2024–2025, and a structural shift toward staying private longer have lengthened time to exit, increased the share of down rounds, and pushed liquidation preference stacks higher. The SEC’s investor education materials on private placements flag many of these dynamics, and outlets like Bloomberg have documented the surge in 2x and participating preferences during the recent venture cycle.
To make a rational decision about a job offer or about whether to exercise options, you need a framework for startup equity expected value. The basic formula is straightforward: probability of a liquidity event multiplied by expected payout in that event, minus the cost of exercising and the taxes you owe along the way. The discipline is in being honest about each input.
Suppose you are granted 10,000 options at a $5 strike. Consider three scenarios: a 70% chance the company fails or stays a zombie ($0 to common), a 20% chance of a modest exit where common stock comes out at $3 per share net of preferences (which is below your strike), and a 10% chance of a strong exit at $40 per share ($350,000 gross spread on the grant). Expected gross value works out to roughly $35,000 — and after exercise costs, AMT, and ordinary income or capital gains tax, the net can easily turn marginal or even negative.
This is where startup equity expected value departs sharply from “this could be worth $400k!” headline math. The headline number multiplies grant size by a hopeful per-share price and ignores both the strike, the taxes, and the probability weighting. A more rigorous approach — the kind used by institutional investors when they price illiquid equity — discounts those scenarios appropriately and is honest about the dropout rate. Aption’s Equity Simulator lets you stress-test the assumptions with your own grant numbers.
When people argue that the odds are not really that bad, they often cite spectacular outcomes from companies like Stripe, Databricks, OpenAI, or Coinbase. Those outcomes are real, and they are part of why startup options remain a meaningful form of compensation. But selection bias is doing a lot of work in those arguments — the names you remember are the ones that worked.
Horsley Bridge data on venture funds, repeatedly cited by Sequoia and Andreessen Horowitz partners, shows that roughly 6% of investments generate more than 60% of returns, and the top 1% of investments often produce more than 25% of total return. That is the venture power law in action. For an employee, the implication is that even within a good portfolio of grants, a small number of names drive almost all of the gain. If you have only one or two grants in your career, the odds of being in that small fraction are not in your favor — even if you are a great employee at a great company.
Knowing what percentage of startup options pay out should change how you negotiate, exercise, and diversify. First, treat your option grant as a risky asset, not a guaranteed bonus. Negotiate base salary as if the equity might be worth zero, because it often will be. Second, before writing a check to exercise, ask whether the implied probability-weighted return clears your hurdle rate net of taxes. The IRS’s guidance on stock options explains the mechanical differences between ISOs and NSOs, and those differences are material to expected value.
Third, if you find yourself with a meaningful concentrated equity position, consider strategies that reduce idiosyncratic risk. The classic approach in private wealth has been to wait for tender offers, secondary sales, or IPO unlocks. A newer approach is equity pooling, where you swap part of your concentrated position for diversified exposure across a portfolio of comparable startups. Our Introduction to Equity Pooling walks through the mechanics in detail.
I’ve seen too many employees treat exercise decisions as all-or-nothing — write the full check or lose everything — when in fact partial diversification is usually a better fit for the underlying risk profile. The Should I Buy My Equity? guide for venture-backed employees walks through the decision tree, including how to think about strike, AMT exposure, and time to exit when you are sizing your exercise.
A useful mental model is to think of your option grant the way an early-stage VC thinks of a single check. Even great VCs expect most of their portfolio to fail. They size positions accordingly and diversify across enough companies that the power-law winners can carry the fund. Most employees never get that diversification — their entire equity exposure is to one company, and often to one role at one company.
When the recruiting deck shows you a 10x or 100x scenario, ask: what is the probability of that outcome, what is the probability of zero, and what does the strike-plus-tax bill look like in each case? If those numbers don’t pencil out, that is information — not necessarily a reason to skip a great job, but a reason to negotiate harder, save more from base salary, and consider tools that let you turn part of your concentrated grant into a more diversified position.
Across the data, what percentage of startup options pay out depends heavily on stage, market cycle, and capital structure, but for most venture-backed grants the realistic range is a 5–20% chance of any payout above strike-plus-taxes, with a much smaller probability of a life-changing outcome. That is not a reason to refuse equity — it is a reason to size and structure your bet thoughtfully.
Aption was built for the holders sitting in the middle of these distributions — concentrated, illiquid, and unable to diversify on their own. If you would like to explore what swapping some of your concentrated equity for diversified exposure could look like, you can Get an Offer, or read The Problem for Stock & Option Holders for context on why this market exists.
The author name used in this article may be a pen name or pseudonym and is used for illustrative and editorial purposes only. This article is for informational purposes only and does not constitute investment, tax, or legal advice. Past performance and historical statistics are not indicative of future results. Consult qualified professionals before making financial decisions about exercising options, tax planning, or portfolio strategy.
Michael is a financial analyst and equity markets researcher who covers startup valuations, secondary markets, and alternative investment vehicles. He previously led equity research at a top-tier investment bank.